Prevalence of depressive symptoms and predictors of treatment among US adults from 2005 to 2010 S Wittayanukorn, J Qian, RA Hansen General hospital psychiatry 36 (3), 330-336, 2014 | 109 | 2014 |
Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan S Wittayanukorn, SC Westrick, RA Hansen, N Billor, K Braxton-Lloyd, ... Journal of Managed Care Pharmacy 19 (5), 385-395, 2013 | 90 | 2013 |
Prevention of Trastuzumab and Anthracycline-induced Cardiotoxicity Using Angiotensin-converting Enzyme Inhibitors or β-blockers in Older Adults With Breast Cancer S Wittayanukorn, J Qian, SC Westrick, B Billor, B Johnson, RA Hansen American Journal of Clinical Oncology, 2017 | 60 | 2017 |
Interventions for adherence with oral chemotherapy in hematological malignancies: a systematic review J Kavookjian, S Wittayanukorn Research in Social and Administrative Pharmacy 11 (3), 303-314, 2015 | 37 | 2015 |
Cardiotoxicity in targeted therapy for breast cancer: A study of the FDA adverse event reporting system (FAERS) S Wittayanukorn, J Qian, BS Johnson, RA Hansen Journal of Oncology Pharmacy Practice 23 (2), 93-102, 2017 | 35 | 2017 |
Predictive analysis of first abbreviated new drug application submission for new chemical entities based on machine learning methodology M Hu, A Babiskin, S Wittayanukorn, A Schick, M Rosenberg, X Gong, ... Clinical Pharmacology & Therapeutics 106 (1), 174-181, 2019 | 15 | 2019 |
Factors that have an impact on abbreviated new drug application (ANDA) submissions S Wittayanukorn, M Rosenberg, A Schick, M Hu, Z Wang, A Babiskin, ... Therapeutic Innovation & Regulatory Science 54, 1372-1381, 2020 | 11 | 2020 |
Comparative outcomes of treatment initiation with brand vs. generic warfarin in older patients RJ Desai, C Gopalakrishnan, S Dejene, AS Sarpatwari, R Levin, ... Clinical Pharmacology & Therapeutics 107 (6), 1334-1342, 2020 | 9* | 2020 |
Treatment patterns among breast cancer patients in the United States using two national surveys on visits to physicians' offices and hospital outpatient departments S Wittayanukorn, J Qian, SC Westrick, N Billor, B Johnson, RA Hansen Research in Social and Administrative Pharmacy 11 (5), 708-720, 2015 | 9 | 2015 |
Patterns of psychiatric emergency department utilization among community-dwelling Medicare beneficiaries under 65. J Qian, S Wittayanukorn, RA Hansen Psychological services 14 (3), 387, 2017 | 6 | 2017 |
Data-driven automated classification algorithms for acute health conditions: applying PheNorm to COVID-19 disease JC Smith, BD Williamson, DJ Cronkite, D Park, JM Whitaker, ... Journal of the American Medical Informatics Association 31 (3), 574-582, 2024 | 4 | 2024 |
Factors associated with psychotropic prescriptions, psychiatric hospitalization, and spending among Medicare beneficiaries under 65 J Qian, S Wittayanukorn, G McGuffey, R Hansen Disability and Health Journal 8 (3), 424-433, 2015 | 4 | 2015 |
What factors may impact the likelihood of first abbreviated new drug application (ANDA) submission for a reference product? S Wittayanukorn, M Rosenberg, A Schick, M Hu, Z Wang, A Babiskin, ... Value in Health 21, S116, 2018 | 3 | 2018 |
Risk of Cardiotoxicity and All-Cause Mortality in Breast Cancer Patients after Adjuvant Chemotherapy or Hormonal Therapy S Wittayanukorn, J Qian, SC Westrick, N Billor, B Johnson, RA Hansen Value in Health 18 (3), A190, 2015 | 1 | 2015 |
Patterns of Psychotropic prescription Utilization among disabled Medicare Beneficiaries Under 65 J Qian, S Wittayanukorn, RA Hansen Value in Health 18 (3), A125, 2015 | 1 | 2015 |
US emergency department visits for prescription opioid adverse events in older adults, 2016 to 2018 C Greene, R Radin, S Wittayanukorn, JG Naples, CL Collins, J Staffa PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 389-390, 2022 | | 2022 |
Data-driven approaches to improve phenotype sensitivity using EHR data S Toh, D Carrell, JC Smith, D Park, J Whitaker, MF McLemore, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 549-549, 2022 | | 2022 |
Benzodiazepine use, nonmedical use, and overdose in the US S Wittayanukorn, A Seitz, D Bak, R Radin, S Karami, N Sadiq, R Gill, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 155-156, 2021 | | 2021 |
Prescribing and non-medical use of tramadol and other opioid analgesics: US, 2009-2018 S Wittayanukorn, I Ibrahim, R Radin, S Karami, R Gill, G Chai, J McAninch PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 485-486, 2020 | | 2020 |
PATTERNS OF BIOEQUIVALENCE RECOMMENDATIONS AND TRENDS OF ABBREVIATED NEW DRUG APPLICATIONS APPROVAL OVER TIME S Wittayanukorn, A Babiskin, S Dutcher, X Pu, M Hu, L Zhao, ... Value in Health 19 (3), A286, 2016 | | 2016 |